Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- The head of the U.S. Food and Drug ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

The PBS series is a both a coming-of-age story and a historical document, about the lasting effects on young people of the ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

"You could replace Peter Marks with a bobblehead doll that just stamps approval and you would have the same outcome at FDA ...

New York, 15 other states and Washington, D.C., had sued the Trump administration to get the funding restored.

The vaccine causes your body to make a small amount of COVID protein, which your body recognizes as foreign and destroys.

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...

Chalkbeat reports that the impact of COVID-era closures-the ways schools rose to meet the moment and the ways they ...

COVID was all we could think about. Today, we'd rather forget about lockdowns, testing lines and social distancing. But the ...